Immediate Impact
5 from Science/Nature 59 standout
Citing Papers
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Emre Yıldırım being referenced
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events
2020
Hepatogastroenterology
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Emre Yıldırım | 226 | 93 | 170 | 149 | 29 | 631 | |
| J.B.M.J. Jansen | 109 | 75 | 203 | 76 | 28 | 559 | |
| Sylvain Mukenge | 122 | 55 | 147 | 108 | 24 | 723 | |
| Ulrika Smedh | 69 | 54 | 207 | 93 | 38 | 689 | |
| Masako Yokoyama | 134 | 53 | 190 | 66 | 40 | 699 | |
| Rehfeld Jf | 182 | 172 | 219 | 37 | 27 | 654 | |
| Giuseppe De | 241 | 40 | 178 | 35 | 29 | 669 | |
| A. P. Gokin | 139 | 31 | 123 | 49 | 42 | 620 | |
| Isabel Silva | 146 | 38 | 70 | 38 | 39 | 669 | |
| Evangelos Bozas | 97 | 172 | 162 | 36 | 30 | 698 | |
| G. Lux | 74 | 29 | 296 | 144 | 33 | 595 |
All Works
Loading papers...